Clinical trial
Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors
NCT00497081 · San Francisco Department of Public Health, Other · Completed
Key facts
| NCT number | NCT00497081 |
|---|---|
| Title | Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors |
| Official title | Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors |
| Lead sponsor | San Francisco Department of Public Health, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH Public Health Foundation Enterprises, Inc. |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Substance Abuse, HIV Infections |
| Intervention type | Drug |
| Interventions | mirtazapine, placebo |
| Enrollment | 60 |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Jul 6, 2007 |
| Last update posted | Jan 5, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: